β-Thujaplicin inhibits basal-like mammary tumor growth by regulating glycogen synthase kinase-3β/β-catenin signaling

2019 ◽  
Vol 10 (5) ◽  
pp. 2691-2700 ◽  
Author(s):  
Jing Chen ◽  
Jiwon Ko ◽  
Jin Tae Kim ◽  
Jae Seok Cho ◽  
Shuai Qiu ◽  
...  
Keyword(s):  
Tumor Growth ◽  
Chronic Diseases ◽  
Mammary Tumor ◽  
Glycogen Synthase ◽  
Glycogen Synthase Kinase ◽  
Glycogen Synthase Kinase 3Β ◽  
Mammary Tumor Growth

β-Thujaplicin, a natural monoterpenoid, has been demonstrated to exert health beneficial activities in chronic diseases.

scholarly journals Glycogen synthase kinase 3β inhibitors induce apoptosis in ovarian cancer cells and inhibit in-vivo tumor growth

2011 ◽  
pp. 1 ◽  
Author(s):  
Tyvette S. Hilliard ◽  
Irina N. Gaisina ◽  
Amanda G. Muehlbauer ◽  
Arsen M. Gaisin ◽  
Franck Gallier ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Tumor Growth ◽  
Cancer Cells ◽  
Glycogen Synthase ◽  
Glycogen Synthase Kinase ◽  
Ovarian Cancer Cells ◽  
Glycogen Synthase Kinase 3Β

Is Going for Cure in CML Targeting Aberrant Glycogen Synthase Kinase 3β?

2017 ◽  
Vol 18 (4) ◽  
pp. 396-404
Author(s):  
Concetta Saponaro ◽  
Michele Maffia ◽  
Nicola Renzo ◽  
Addolorata Coluccia
Keyword(s):  
Glycogen Synthase ◽  
Glycogen Synthase Kinase ◽  
Glycogen Synthase Kinase 3Β
Sign in / Sign up

Export Citation Format

Share Document